1. Home
  2. KRYS vs ENS Comparison

KRYS vs ENS Comparison

Compare KRYS & ENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • ENS
  • Stock Information
  • Founded
  • KRYS 2015
  • ENS 1991
  • Country
  • KRYS United States
  • ENS United States
  • Employees
  • KRYS N/A
  • ENS N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • ENS Industrial Machinery/Components
  • Sector
  • KRYS Health Care
  • ENS Technology
  • Exchange
  • KRYS Nasdaq
  • ENS Nasdaq
  • Market Cap
  • KRYS 4.3B
  • ENS 3.5B
  • IPO Year
  • KRYS 2017
  • ENS N/A
  • Fundamental
  • Price
  • KRYS $152.08
  • ENS $93.61
  • Analyst Decision
  • KRYS Strong Buy
  • ENS Strong Buy
  • Analyst Count
  • KRYS 11
  • ENS 2
  • Target Price
  • KRYS $204.27
  • ENS $117.50
  • AVG Volume (30 Days)
  • KRYS 273.6K
  • ENS 334.0K
  • Earning Date
  • KRYS 08-04-2025
  • ENS 08-06-2025
  • Dividend Yield
  • KRYS N/A
  • ENS 1.03%
  • EPS Growth
  • KRYS 109.01
  • ENS 38.31
  • EPS
  • KRYS 4.16
  • ENS 8.99
  • Revenue
  • KRYS $333,448,000.00
  • ENS $3,617,579,000.00
  • Revenue This Year
  • KRYS $40.10
  • ENS $2.47
  • Revenue Next Year
  • KRYS $49.73
  • ENS $3.32
  • P/E Ratio
  • KRYS $36.60
  • ENS $10.36
  • Revenue Growth
  • KRYS 247.53
  • ENS 1.00
  • 52 Week Low
  • KRYS $122.80
  • ENS $76.57
  • 52 Week High
  • KRYS $213.52
  • ENS $112.53
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 58.86
  • ENS 63.02
  • Support Level
  • KRYS $147.35
  • ENS $92.36
  • Resistance Level
  • KRYS $154.99
  • ENS $94.50
  • Average True Range (ATR)
  • KRYS 4.29
  • ENS 1.78
  • MACD
  • KRYS 0.08
  • ENS 0.63
  • Stochastic Oscillator
  • KRYS 66.32
  • ENS 87.88

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

Share on Social Networks: